Two hormones, one puzzle Two hormones from the same organ can push blood sugar in opposite directions. The story begins a century ago, with a critically ill boy in Toronto and a surprise in a Rochester laboratory. Toronto, 1921 — the insulin research In 1921, at the University of Toronto, Frederick Banting and Charles Best tested pancreatic extracts in the laboratory of physiologist John Macleod. Biochemist James Collip made the extract purer. January 23, 1922 — the clinical turning point At Toronto General Hospital, the first injection gave 14-year-old Leonard Thompson only a modest response. On January 23, 1922, Collip’s preparation brought his blood sugar down sharply. The boy improved. Rochester, 1923 — the discovery of glucagon Then came a surprise. In 1923, at the University of Rochester in New York, Charles Kimball and John Murlin reported a substance in pancreatic extracts that raised blood sugar. They called it glucagon. After a meal — insulin Today we know that both signals come from tiny clusters of cells in the pancreas. After a meal, beta cells release insulin. Muscle and fat take up glucose, and the liver stores some as glycogen. Between meals — glucagon Between meals, insulin levels fall. Glucagon from alpha cells tells the liver to release glucose. The liver can break down stored glycogen or make new glucose, helping maintain fuel for the brain. Glucagon as rescue medicine That same liver response makes glucagon useful as a rescue medicine for severe low blood sugar. If the liver’s glycogen is depleted, as in starvation, rescue glucagon can be less effective. The GLP-1 connection And that brings us to GLP-1. This gut hormone can boost insulin release when glucose is elevated and help suppress glucagon. Two discoveries, a century ago, still help us explain what happens after every meal. World Peptide Foundation World Peptide Foundation. Peptides in 2. Every experience matters.